Ninds Preclinical Screening Platform for Pain (Pspp) Tender, USA - 100177349

Procurement Summary

Country : USA

Summary : Ninds Preclinical Screening Platform for Pain (Pspp)

Deadline : 23 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100177349

Document Ref. No. : 75N95024R00054

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : Bethesda, MD 20892
Primary Point of Contact : PLUGGE, RIEKA N
pluggern@nih.gov
Phone Number +1 301 827 7515

USA
Email :pluggern@nih.gov

Tender Details

Description

THIS IS NOT A REQUEST FOR PROPOSALS (RFP). THIS IS A PRE-SOLICITATION ANNOUNCEMENT ONLY. A REQUEST FOR PROPOSALS (RFP) NO. 75N95024R00054, ENTITLED: "NINDS Preclinical Screening Platform for Pain (PSPP)" AS A TOTAL SMALL BUSINESS SET-ASIDE WILL BE ISSUED VIA www.SAM.gov ON OR ABOUT April 23, 2024.The National Institutes of Neurological Disorders and Stroke (NINDS) has a continued need for screening of investigational agents through a Preclinical Screening Platform for Pain (PSPP) in response to the National Institutes of Health (NIH) Helping to End Addiction Long-term (HEAL) initiative. The HEAL initiative (https://www.nih.gov/research-training/medical-research-initiatives/heal-initiative) is a trans-NIH effort to fast-track basic, translational, and clinical research in the field of addiction and pain to address the national opioid crisis. The goal of the PSPP is to foster the development of opioid alternatives to treat all types of pain conditions. As part of the ongoing HEAL Initiative, the PSPP will provide pain researchers from the academic and industry community with a centralized resource for testing compounds, biologics, natural products, and devices for their potential as opioid alternatives. Contributors with a promising non-addictive therapeutic for pain (Contributors) will be invited to submit bioactive investigational agents to the PSPP for testing. These investigational agents will be evaluated to determine if they are non-opiate, metabolically stable compounds that show promise in established and newly developed models of pain. The Contractor shall provide screening of potentially viable investigational agents submitted through the PSPP. NINDS will send investigational agents to the Contractor in a blinded fashion (without structures), and the Contractor shall perform progressive testing funnel established in collaboration with NINDS staff and the External Consultants Board for the PSPP (ECB). The testing will include in-vitro evaluati...
Active Contract Opportunity Notice ID 75N95024R00054 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Presolicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Apr 17, 2024 10:22 am EDT
Original Published Date: Apr 02, 2024 02:45 pm EDT
Updated Response Date: Apr 23, 2024 02:30 pm EDT
Original Response Date: Apr 17, 2024 03:30 pm EDT
Inactive Policy: 15 days after response date
Updated Inactive Date: May 08, 2024
Original Inactive Date: Apr 17, 2024
Initiative: None

Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)

Product Service Code: AN11 - Health R&D Services; Health care services; Basic Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance:

Documents

 Tender Notice